Public/Private Sector Partnership For Emerging Infections
2001
Public/Private Partnerships for Emerging Infections
publication
Evidence: moderate
Author Information
Author(s): Enriqueta C. Bond
Primary Institution: Burroughs Wellcome Fund
Hypothesis
Public/private partnerships can advance our understanding and control of emerging infections.
Conclusion
Public/private partnerships are essential for developing new ways to prevent and treat infectious diseases, especially in developing countries.
Supporting Evidence
- Public/private partnerships can support research, drug development, and policy advancement.
- The Malaria Genome Project has provided new insights into malaria biology and vaccine research.
- Philanthropic investments can play a catalytic role in public health initiatives.
Takeaway
This study shows that working together, governments, companies, and charities can help fight diseases like malaria by sharing resources and knowledge.
Potential Biases
Philanthropic organizations may resist collaborative ventures and have limited funds for research.
Limitations
Philanthropic support is modest compared to industrial and government support for medical research.
Want to read the original?
Access the complete publication on the publisher's website